IRCT20110606006709N22
Recruiting
Phase 3
Comparative of the effect of Combined oral contraceptive pills (COCs) and vitamin D - COCs on Ovulatory dysfunction bleeding (AUB-O) in reproductive age women : A triple blind randomized controlled clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Ovulatory dysfunction bleeding.
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women 18\-45 years old
- •Have at least 2\-3 months of history of excessive, long and irregular bleeding (lack of regular cycle 28\-35, bleeding more than 7 days or heavy)
- •Have a phone number to follow up.
Exclusion Criteria
- •Any cervical abnormality including cervical cancer, infection, trauma or polyp and uterine causes including: leiomyoma, infection, polyp, endometrial hyperplasia, endometrial neoplasia, cancer or the presence of a foreign body based on the patient's statement and medical records.
- •Having any kind of severe psychological stress such as: separation of parents, death of first\-degree family members, etc. in the last 6 months.
- •Having any kind of systemic diseases, such as: thyroid disease (hypothyroidism and hyperthyroidism), adrenal glands, liver, kidney and blood disorders (von Willebrand disease, idiopathic thrombocytopenic purpura, and leukemia) based on the patient's statement and medical records.
- •Daily and regular intake of vitamin D supplements for the past three months.
- •Taking medications that affect the menstrual cycle and bleeding, such as: oral hormonal contraceptives, anticoagulants, serotonin inhibitors, antipsychotics, corticosteroids, hormonal supplements, phenytoin, or herbal supplements such as soy and ginseng.
- •Having premenstrual syndrome.
- •Have any absolute or relative contraindications to the use of combined contraceptive pills, including breast cancer, endometrial cancer, liver disease, deep vein thrombosis, smoking in people 35 years and older, cardiovascular disease, history of stroke, Diabetes, hypertension, migraine, hyperlipidemia, conditions requiring complete immobility, inflammatory bowel disease, major depression, and epilepsy require medication.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Comparative study on the impact of combined oral contraceptive pills and Progestrogen only pills on the prevalence of bacterial vaginosis using Nugent score : a randomized-controlled trialTo study prevalence of bacterial vaginosisTCTR20190313002Faculty of Medicine Siriraj Hospital, Mahidol University200
Not yet recruiting
Phase 2
To study the efficacy of administration of metformin into thyroid nodules and compare it with oral metformin in patients with benign goiter and normal thyroid functioHealth Condition 1: E049- Nontoxic goiter, unspecifiedCTRI/2019/07/020053IPGMER
Recruiting
Not Applicable
To study the effectiveness of combined oral contraceptives(drugs with female hormones) and myoinositol (drug that reduces insulin resistance) with life style modifications in adolescent and young female with Polycystic Ovarian Syndrome( disease with multiple cysts in ovary)Health Condition 1: null- Patients who are diagnosed case of Polycystic Ovarian SyndromeCTRI/2018/05/014055Khushbu Pandey
Active, not recruiting
Phase 1
Study to compare the effectiveness of drinking water or receiving endovenous hydration to prevent complications in the kidney in patients with renal insufficiency grade III underwent performing computed tomography (CT)Patients with renal failure undergoing a computed tomography scan with contrastMedDRA version: 19.0Level: PTClassification code 10038435Term: Renal failureSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Not possible to specifyEUCTR2016-002032-33-ESFundacio Privada Clinic per a la Recerca Biomedica
Recruiting
Phase 3
The effect of combination therapy on feeding performance in premature infantsIRCT20171023036956N2Iran University of Medical Sciences44